Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET

[en] A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics and an automated voxel-based procedure, is presented and validated in a large data set comprising 110 normal controls and 395 patients with probable Alzheimer's disease (AD) that were studied in eight participating centers. The effect of differences in spatial resolution of PET scanners was minimized effectively by filtering and masking. In controls FDG uptake declined significantly with age in anterior cingulate and frontolateral perisylvian cortex. In patients with probable AD decline of FDG uptake in posterior cingulate, temporoparietal, and prefrontal association cortex was related to dementia severity. These effects were clearly distinct from age effects in controls, suggesting that the disease process of AD is not related to normal aging. Women with probable AD had significantly more frontal metabolic impairment than men. The new indicator of metabolic abnormality in AD-related regions provided 93% sensitivity and specificity for distinction of mild to moderate probable AD from normals, and 84% sensitivity at 93% specificity for detection of very mild probable AD (defined by Mini Mental Score 24 or better). All regions related to AD severity were already affected in very mild AD, suggesting that all vulnerable areas are affected to a similar degree already at disease onset. Ventromedial frontal cortex was also abnormal. In conclusion, automated analysis of multicenter FDG PET is feasible, provides insights into AD pathophysiology, and can be used potentially as a sensitive biomarker for early AD diagnosis. (C) 2002 Elsevier Science (USA).

Research Center/Unit :

GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège

Disciplines :

Neurology

Author, co-author :

Herholz, K.

Salmon, Eric ; Université de Liège - ULiège > Département des sciences cliniques > Neuroimagerie des troubles de la mémoire et révalid. cogn.

Perani, D.

Baron, J. C.

Holthoff, V.

Frolich, L.

Schonknecht, P.

Ito, K.

Mielke, R.

Kalbe, E.

More authors (15 more)

Language :

English

Title :

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET

Publication date :

September 2002

Journal title :

NeuroImage

ISSN :

1053-8119

eISSN :

1095-9572

Publisher :

Academic Press Inc Elsevier Science, San Diego, United States - California

Volume :

Issue :

Pages :

302-316

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://www.elsevier.com/wps/find/journaldescription.cws_home/622925/description#description

Available on ORBi :

since 16 February 2009

Statistics

Number of views

963 (4 by ULiège)

Number of downloads

2914 (10 by ULiège)

More statistics

Scopus citations^®

689

Scopus citations^®
without self-citations

554

OpenCitations

569

OpenAlex citations

763

Bibliography

Alavi, A., Newberg, A. B., Souder, E., and Berlin, J. A. 1993. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J. Nucl. Med. 34: 1681-1687.
Baron, J. C., Chetelat, G., Desgranges, B., Perchey, G., Landeau, B., de l, S. V., and Eustache, F. 2001. In vivo mapping of gray matter loss with voxel-based morphometry in mild alzheimer's disease. NeuroImage 14: 298-309.
Chu, C. C., Tranel, D., Damasio, A. R., and Van Hoesen, G. W. 1997. The autonomic-related cortex: Pathology in Alzheimer's disease. Cereb. Cortex 7: 86-95.
de Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., Imossi, A., Thorn, E., Bobinski, M., Caraos, C., Lesbre, P., Schlyer, D., Poirier, J., Reisberg, B., and Fowler, J. 2001. Prediction of cognitive decline in normal elderly subjects with 2-F-18-fluoro-2-deoxy-D-glucose positron-emission tomography (FDG PET). Proc. Natl. Acad. Sci. USA 98: 10966-10971.
Desgranges, B., Baron, J. C., de l, S., Petit-Taboue, M. C., Benali, K., Landeau, B., Lechevalier, B., and Eustache, F. 1998. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 121: 611-631.
Fama, R., Sullivan, E. V., Shear, P. K., Marsh, L., Yesavage, J. A., Tinklenberg, J. R., Lim, K. O., and Pfefferbaum, A. 1997. Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease. Arch. Neurol. 54: 719-728.
Folstein, M. F., Folstein, S. E., and McHugh, P. R. 1975. "Minimental state." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12: 189-198.
Friston, K. J., Ashburner, J., Poline, J. B., Frith, C. D., Heather, J. D., and Frackowiak, R. S. J. 1995a. Spatial registration and normalisation of images. Human Brain Mapping 2: 165-189.
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. B., Frith, C. D., and Frackowiak, R. S. J. 1995b. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 2: 189-210.
Garraux, G., Salmon, E., Degueldre, C., Lemaire, C., Laureys, S., and Franck, G. 1999. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. NeuroImage 10: 149-162.
Grady, C. L., Berg, G., Carson, R. E., Daube-Witherspoon, M. E., Friedland, R. P., and Rapoport, S. I. 1989. Quantitative comparison of cerebral glucose metabolic rates from two positron emission tomographs. J. Nucl. Med. 30: 1386-1392.
Grigoletto, F., Zappala, G., Anderson, D. W., and Lebowitz, B. D. 1999. Norms for the Mini-Mental State Examination in a healthy population. Neurology 53: 315-320.
Grober, E., Buschke, H., Crystal, H., Bang, S., and Dresner, R. 1988. Screening for dementia by memory testing. Neurology 38: 900-903.
Haxby, J. V., Duara, R., Grady, C. L., Cutler, N. R., and Rapoport, S. I. 1985. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cereb. Blood Flow Metab. 5: 193-200.
Haxby, J. V., Grady, C. L., Koss, E., Horwitz, B., Heston, L., Schapiro, M., Friedland, R. P., and Rapoport, S. I. 1990. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47: 753-760.
Henderson, V. W., and Buckwalter, J. G. 1994. Cognitive deficits of men and women with Alzheimer's disease. Neurology 44: 90-96.
Herholz, K. 1995. FDG PET and differential diagnosis of dementia. Alzheimer Dis. Assoc. Disorders 9: 6-16.
Herholz, K., Adams, R., Kessler, J., Szelies, B., Grond, M., and Heiss, W. D. 1990. Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1: 156-164.
Herholz, K., Nordberg, A., Salmon, E., Perani, D., Kessler, J., Mielke, R., Halber, M., Jelic, V., Almkvist, O., Collette, F., Alberoni, M., Kennedy, A., Hasselbalch, S., Fazio, F., and Heiss, W.-D. 1999. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia Geriatr. Cog. Disord. 10: 494-504.
Herholz, K., Perani, D., Salmon, E., Franck, G., Fazio, F., Heiss, W. D., and Comar, D. 1993. Comparability of FDG PET studies in probable Alzheimer's disease. J. Nucl. Med. 34: 1460-1466.
Hoffman, J. M., Welsh-Bohmer, K. A., Hanson, M., Crain, B., Hulette, C., Earl, N., and Coleman, R. E. 2000. FDG PET imaging in patients with pathologically verified dementia. J. Nucl. Med. 41: 1920-1928.
Ibanez, V., Pietrini, P., Alexander, G. E., Furey, M. L., Teichberg, D., Rajapakse, J. C., Rapoport, S. I., Schapiro, M. B., and Horwitz, B. 1998. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50: 1585-1593.
Ichimiya, A., Herholz, K., Mielke, R., Kessler, J., Slansky, I., and Heiss, W. D. 1994. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: A factor analytic study. J. Neurol. Sci. 123: 11-17.
Jagust, W. J., Eberling, J. L., Richardson, B. C., Reed, B. R., Baker, M. G., Nordahl, T. E., and Budinger, T. F. 1993. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res. 629: 189-198.
Kippenhan, J. S., Barker, W. W., Pascal, S., Nagel, J., and Duara, R. 1992. Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's disease subjects. J. Nucl. Med. 33: 1459-1467.
Kuhl, D. E., Metter, E. J., Riege, W. H., and Hawkins, R. A. 1984. The effect of normal aging on patterns of local cerebral glucose utilization. Ann. Neurol. 15(Suppl): S133-137.
Lim, A., Tsuang, D., Kukull, W., Nochlin, D., Leverenz, J., Mccormick, W., Bowen, J., Teri, L., Thompson, J., Peskind, E. R., Raskind, M., and Larson, E. B. 1999. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am. Geriatr. Soc. 47: 564-569.
Loewenstein, D. A., Barker, W. W., Chang, J. Y., Apicella, A., Yoshii, F., Kothari, P., Levin, B., and Duara, R. 1989. Predominant left hemisphere metabolic dysfunction in dementia. Arch. Neurol. 46: 146-152.
Mattis, S. 1988 Dementia Rating Scale (DRS). Psychological Assessment Resources, Inc., Odessa, FL.
Mazziotta, J. C., Phelps, M. E., Plummer, D., and Kuhl, D. E. 1981. Quantitation in positron emission computed tomography: 5. Physical-Anatomical effects. J. Comput. Assist. Tomogr. 5: 734-743
Meltzer, C. C., Kinahan, P. E., Greer, P. J., Nichols, T. E., Comtat, C., Cantwell, M. N., Lin, M. P., and Price, J. C. 1999. Comparative evaluation of MR-based partial-volume correction schemes for PET. J. Nucl. Med. 40: 2053-2065.
Meltzer, C. C., Zubieta, J. K., Brandt, J., Tune, L. E., Mayberg, H. S., and Frost, J. J. 1996. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 47: 454-461.
Mendez, M. F., Mastri, A. R., Sung, J. H., and Frey, W. H. 1992. Clinically diagnosed Alzheimer disease: Neuropathologic findings in 650 cases. Alzheimer Dis. Assoc. Disord. 6: 35-43.
Messa, C., Perani, D., Lucignani, G., Zenorini, A., Zito, F., Rizzo, G., Grassi, F., Del Sole, A., Franceschi, M., Gilardi, M. C., et al. 1994. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: Comparison with fluorine-18-FDG PET. J. Nucl. Med. 35: 210-216.
Metz, C. E. 1978. Basic principles of ROC analysis. Semin. Nuclear Med. 8: 283-298.
Mielke, R., Herholz, K., Grond, M., Kessler, J., and Heiss, W. D. 1992. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol. Aging 13: 93-98.
Mielke, R., Pietrzyk, U., Jacobs, A., Fink, G. R., Ichimiya, A., Kessler, J., Herholz, K., and Heiss, W. D. 1994. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur. J. Nucl. Med. 21: 1052-1060.
Minoshima, S., Frey, K. A., Koeppe, R. A., Foster, N. L., and Kuhl, D. E. 1995. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J. Nucl. Med. 36: 1238-1248.
Morris, J. C. 1993. The Clinical Dementia Rating (CDR): Current version and scoring rules [see comments]. Neurology 43: 2412-2414.
Morris, J. C., McKeel, D. W., Jr., Fulling, K., Torack, R. M., and Berg, L. 1988. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann. Neurol. 24: 17-22.
Mungas, D., Marshall, S. C., Weldon, M., Haan, M., and Reed, B. R. 1996. Age and education correction of Mini-Mental State Examination for English and Spanish-speaking elderly. Neurology 46: 700-706.
Perani, D., and Cappa, S. F. 2001. Brain imaging in normal aging and dementia. In Normal Aging and Dementia. Handbook of Neuropsychology (J. Grafman and F. Boller, Eds.). Elsevier, Amsterdam.
Petit-Taboue, M. C., Landeau, B., Desson, J. F., Desgranges, B., and Baron, J. C. 1998. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. NeuroImage 7: 176-184.
Pietrzyk, U., Herholz, K., Schuster, A., von Stockhausen, H. M., Lucht, H., and Heiss, W. D. 1996. Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI. Eur. J. Radiol. 21: 174-182.
Rapoport, S. I. 1991. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis - A critical review. Cerebrovasc. Brain Metab. Rev. 3: 297-335.
Rapoport, S. I. 1997. Discriminant analysis of brain imaging data identifies subjects with early Alzheimer's disease. Int. Psychogeriatr. 9 (Suppl. 1): 229-235.
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., and Osborne, D. 1996. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334: 752-758.
Reisberg, B., Ferris, S. H., DeLeon, M. J., and Crook, T. 1982. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psych. 139: 1136-1139.
Salmon, E., Collette, F., Degueldre, C., Lemaire, C., and Franck, G. 2000. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Human Brain Mapping 10: 39-48.
Salmon, E., Sadzot, B., Maquet, P., Degueldre, C., Lemaire, C., Rigo, P., Comar, D., and Franck, G. 1994. Differential diagnosis of Alzheimer's disease with PET. J. Nucl. Med. 35: 391-398.
Signorini, M., Paulesu, E., Friston, K., Perani, D., Colleluori, A., Lucignani, G., Grassi, F., Bettinardi, V., Frackowiak, R. S. J., and Fazio, F. 1999. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. NeuroImage 9: 63-80.
Silverman, D. H., Small, G. W., Chang, C. Y., Lu, C. S., Kung de Aburto, M. A., Chen, W., Czemin, J., Rapoport, S. I., Pietrini, P., Alexander, G. E., Schapiro, M. B., Jagust, W. J., Hoffman, J. M., Welsh-Bohmer, K. A., Alavi, A., Clark, C. M., Salmon, E., de Leon, M. J., Mielke, R., Cummings, J. L., Kowell, A. P., Gambhir, S. S., Hoh, C. K., and Phelps, M. E. 2001. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 286: 2120-2127.
Small, G. W., Ercoli, L. M., Silverman, D. H., Huang, S. C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., Mazziotta, J. C., Saxena, S., Wu, H. M., Mega, M. S., Cummings, J. L., Saunders, A. M., Pericak-Vance, M. A., Roses, A. D., Barrio, J. R., and Phelps, M. E. 2000. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 97: 6037-6042.
Steel, R. D. G., and Torrie, J. H. 1980 Principles and Procedures of Statistics. A Biometrical Approach. McGraw-Hill, New York.
Thompson, P. M., Moussai, J., Zohoori, S., Goldkorn, A., Khan, A. A., Mega, M. S., Small, G. W., Cummings, J. L., and Toga, A. W. 1998. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb. Cortex 8: 492-509.
Thompson, P. M., Schwartz, C., Lin, R. T., Khan, A. A., and Toga, A. W. 1996. Three-dimensional statistical analysis of sulcal variability in the human brain. J. Neurosci. 16: 4261-4274.
Wechsler, D. 1987. Wechsler Memory Scale-Revised. Psychological Corp., New York.